A Randomized, open-label, Phase 2 Study of Adjuvant Apalutamide or Standard of Care in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy (ADAM)

Basic data for this project

Type of projectOwn resources project
Duration at the University of Münstersince 01/01/2020

Description

KeywordsApalutamid; Prostatakrebs

Project management at the University of Münster

Eveslage, Maria
Institute of Biostatistics and Clinical Research (IBKF)